- Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program. Houghton, P.J., Morton, C.L., Kolb, E.A., Gorlick, R., Lock, R., Carol, H., Reynolds, C.P., Maris, J.M., Keir, S.T., Billups, C.A., Smith, M.A. Pediatr. Blood. Cancer (2008)